Literature DB >> 19956504

Biology of SNU cell lines.

Ja-Lok Ku1, Jae-Gahb Park.   

Abstract

SNU (Seoul National University) cell lines have been established from Korean cancer patients since 1982. Of these 109 cell lines have been characterized and reported, i.e., 17 colorectal carcinoma, 12 hepatocellular carcinoma, 11 gastric carcinoma, 12 uterine cervical carcinoma, 17 B-lymphoblastoid cell lines derived from cancer patients, 5 ovarian carcinoma, 3 malignant mixed Mllerian tumor, 6 laryngeal squamous cell carcinoma, 7 renal cell carcinoma, 9 brain tumor, 6 biliary tract, and 4 pancreatic carcinoma cell lines. These SNU cell lines have been distributed to biomedical researchers domestic and worldwide through the KCLB (Korean Cell Line Bank), and have proven to be of value in various scientific research fields. The characteristics of these cell lines have been reported in over 180 international journals by our laboratory and by many other researchers from 1987. In this paper, the cellular and molecular characteristics of SNU human cancer cell lines are summarized according to their genetic and epigenetic alterations and functional analysis.

Entities:  

Keywords:  Cancer; Cancer research; Cell culture; Cell line; SNU

Year:  2005        PMID: 19956504      PMCID: PMC2785416          DOI: 10.4143/crt.2005.37.1.1

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  184 in total

1.  Co-expression of urokinase-type plasminogen activator and its receptor in human gastric-cancer cell lines correlates with their invasiveness and tumorigenicity.

Authors:  I K Park; B J Kim; Y J Goh; M A Lyu; C G Park; E S Hwang; Y H Kook
Journal:  Int J Cancer       Date:  1997-05-29       Impact factor: 7.396

2.  Establishment and characterization of seven human renal cell carcinoma cell lines.

Authors:  K H Shin; J L Ku; W H Kim; S E Lee; C Lee; S W Kim; J G Park
Journal:  BJU Int       Date:  2000-01       Impact factor: 5.588

Review 3.  The IGF axis and hepatocarcinogenesis.

Authors:  J G Scharf; F Dombrowski; G Ramadori
Journal:  Mol Pathol       Date:  2001-06

4.  Functional interaction of lithocholic acid conjugates with M3 muscarinic receptors on a human colon cancer cell line.

Authors:  Kunrong Cheng; Ying Chen; Piotr Zimniak; Jean-Pierre Raufman; Yinghua Xiao; Harold Frucht
Journal:  Biochim Biophys Acta       Date:  2002-10-09

5.  TNF-alpha induces apoptosis mediated by AEBSF-sensitive serine protease(s) that may involve upstream caspase-3/CPP32 protease activation in a human gastric cancer cell line.

Authors:  I C Park; M J Park; T B Choe; J J Jang; S I Hong; S H Lee
Journal:  Int J Oncol       Date:  2000-06       Impact factor: 5.650

6.  Cloning and functional study of a novel human metallothionein-I isoform induced by paraquat.

Authors:  Cheol-Hee Choi
Journal:  Biochem Biophys Res Commun       Date:  2003-05-02       Impact factor: 3.575

7.  Mutational analysis of BRAF and K-ras in gastric cancers: absence of BRAF mutations in gastric cancers.

Authors:  Il-Jin Kim; Jae-Hyun Park; Hio Chung Kang; Yong Shin; Hye-Won Park; Hye-Rin Park; Ja-Lok Ku; Seok-Byung Lim; Jae-Gahb Park
Journal:  Hum Genet       Date:  2003-09-25       Impact factor: 4.132

8.  Characterization of cell lines established from human hepatocellular carcinoma.

Authors:  J G Park; J H Lee; M S Kang; K J Park; Y M Jeon; H J Lee; H S Kwon; H S Park; K S Yeo; K U Lee
Journal:  Int J Cancer       Date:  1995-07-28       Impact factor: 7.396

9.  Chromogranin A expression in normal and malignant human tissues.

Authors:  L J Helman; A F Gazdar; J G Park; P S Cohen; J D Cotelingam; M A Israel
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

10.  Chemosensitivity patterns and expression of human multidrug resistance-associated MDR1 gene by human gastric and colorectal carcinoma cell lines.

Authors:  J G Park; B S Kramer; S L Lai; L J Goldstein; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1990-02-07       Impact factor: 13.506

View more
  44 in total

1.  Genomic and proteomic characterization of ARID1A chromatin remodeller in ampullary tumors.

Authors:  Anca Nastase; Jin Yao Teo; Hong Lee Heng; Cedric Chuan Young Ng; Swe Swe Myint; Vikneswari Rajasegaran; Jia Liang Loh; Ser Yee Lee; London Lucien Ooi; Alexander Yaw Fui Chung; Pierce Kah Hoe Chow; Peng Chung Cheow; Wei Keat Wan; Rafy Azhar; Avery Khoo; Sam Xin Xiu; Syed Muhammad Fahmy Alkaff; Ioana Cutcutache; Jing Quan Lim; Choon Kiat Ong; Vlad Herlea; Simona Dima; Dan G Duda; Bin Tean Teh; Irinel Popescu; Tony Kiat Hon Lim
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

2.  Modulation of transcription factor binding and epigenetic regulation of the MLH1 CpG island and shore by polymorphism rs1800734 in colorectal cancer.

Authors:  Andrea J Savio; Bharati Bapat
Journal:  Epigenetics       Date:  2017-03-17       Impact factor: 4.528

3.  Aberrant GATA2 epigenetic dysregulation induces a GATA2/GATA6 switch in human gastric cancer.

Authors:  S H Song; M S Jeon; J W Nam; J K Kang; Y J Lee; J Y Kang; H P Kim; S W Han; G H Kang; T Y Kim
Journal:  Oncogene       Date:  2017-11-06       Impact factor: 9.867

4.  The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines.

Authors:  Hyun-Jin Nam; Hwang-Phill Kim; Young-Kwang Yoon; Sang-Hyun Song; Ah-Rum Min; Sae-Won Han; Seock-Ah Im; Tae-You Kim; Do-Youn Oh; Yung-Jue Bang
Journal:  Invest New Drugs       Date:  2011-12-25       Impact factor: 3.850

5.  Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy.

Authors:  Yeonjoo Jung; Jinah Park; Tai Young Kim; Jung-Hyun Park; Hyun-Soon Jong; Seock-Ah Im; Keith D Robertson; Yung-Jue Bang; Tae-You Kim
Journal:  J Mol Med (Berl)       Date:  2007-06-15       Impact factor: 4.599

6.  Decreased mitochondrial OGG1 expression is linked to mitochondrial defects and delayed hepatoma cell growth.

Authors:  Young-Kyoung Lee; Hwang-Guem Youn; Hee-Jung Wang; Gyesoon Yoon
Journal:  Mol Cells       Date:  2013-05-14       Impact factor: 5.034

7.  Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.

Authors:  Seon-Hyeong Lee; Nayeon Kim; Se-Jin Kim; Jaewhan Song; Young-Dae Gong; Soo-Youl Kim
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-21       Impact factor: 4.553

8.  Development of a Tetravalent Anti-GPA33/Anti-CD3 Bispecific Antibody for Colorectal Cancers.

Authors:  Zhihao Wu; Hong-Fen Guo; Hong Xu; Nai-Kong V Cheung
Journal:  Mol Cancer Ther       Date:  2018-08-06       Impact factor: 6.261

9.  Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer.

Authors:  Hyun-A Kim; Bon-Kyoung Koo; Ji-Hoon Cho; Yoon-Young Kim; Jinwoo Seong; Hee Jin Chang; Young Min Oh; Daniel E Stange; Jae-Gahb Park; Daehee Hwang; Young-Yun Kong
Journal:  J Clin Invest       Date:  2012-08-06       Impact factor: 14.808

10.  The glutathione peroxidase 8 (GPX8)/IL-6/STAT3 axis is essential in maintaining an aggressive breast cancer phenotype.

Authors:  Anees Khatib; Balakrishnan Solaimuthu; Michal Ben Yosef; Areej Abu Rmaileh; Mayur Tanna; Gidi Oren; Michal Schlesinger Frisch; Jonathan H Axelrod; Michal Lichtenstein; Yoav D Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.